Healthcare: IPM grew moderately for second consecutive month

12 Jan 2024
5 Min read 
  • Secondary sales of top healthcare companies grew moderately in Dec23.
  •  Indian pharma market (IPM) grew 5.1% YoY in Dec23.
  •  Urology/Cardiac/Neuro therapies grew YoY, while Respiratory/Ophthal therapies declined.
  •  JB Chemical and Intas outperformed IPM in Dec23.
  •  Indian pharma companies achieved mid-single digit growth, while global pharma companies grew modestly.
  •  Acute segments had higher share and grew 9.1% YoY in IPM.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority